Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. OSCR
OSCR logo

OSCR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
13.450
Open
13.300
VWAP
13.31
Vol
7.07M
Mkt Cap
3.99B
Low
13.085
Amount
94.14M
EV/EBITDA(TTM)
--
Total Shares
297.75M
EV
1.62B
EV/OCF(TTM)
1.48
P/S(TTM)
0.31
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
Show More

Events Timeline

(ET)
2026-02-10
06:20:00
Sees FY26 Earnings from Operations at $250M-$450M
select
2026-02-10
06:20:00
Oscar Health Q4 Revenue at $2.81B, Below Consensus
select
2026-02-10
05:50:00
House Judiciary Committee Subpoenas Eight Health Insurers
select
link
2026-01-26 (ET)
2026-01-26
19:50:00
U.S. Markets Rebound Monday, Alphabet and Meta Propel Communication Services
select

News

Fool
9.5
03-11Fool
Analysis of Recent Earnings Reports from CrowdStrike and Wix
  • Mispriced Stocks: The video discusses three stocks considered mispriced, potentially offering buying opportunities for investors, especially in the context of market volatility, necessitating careful risk and reward assessment.
  • CrowdStrike Earnings Highlights: CrowdStrike's recent earnings report indicates strong revenue growth, although specific figures are not disclosed, its leadership in cybersecurity may attract more investor attention, driving stock price increases.
  • Wix Performance: Wix's latest earnings report is also noteworthy; while specific financial data is not provided, its ongoing growth in website building and online services underscores the company's significance in digital transformation, potentially impacting its future market performance.
  • Market Reaction Analysis: The video was published on March 10, 2026, with trading data from March 9, prompting investors to monitor stock price fluctuations of CrowdStrike and Wix to assess the earnings reports' impact on market sentiment.
NASDAQ.COM
2.0
03-11NASDAQ.COM
Analysis of Three Mispriced Stocks and Earnings Reports
  • Earnings Reports: Recent earnings reports from CrowdStrike and Wix indicate their competitive positioning in the market, although specific figures were not disclosed, analysts believe both companies have growth potential ahead.
  • Investment Recommendations: The Motley Fool's analyst team identified 10 stocks for investors, notably excluding Meta Platforms, suggesting a cautious outlook on Meta's future, which could impact its stock performance.
  • Historical Returns Comparison: The Motley Fool Stock Advisor boasts an average return of 952%, significantly outperforming the S&P 500's 191%, indicating that its recommended stocks have excelled in long-term investments, providing a reference for investors.
  • Market Dynamics: The video mentions a
stocktwits
4.5
02-25stocktwits
Trump's State of the Union Influences Market Sentiment
  • Market Sentiment Shift: Investors are digesting President Trump's State of the Union address, leading to a slight market sentiment improvement, with Nasdaq and Russell 2000 futures up 0.1%, while S&P 500 and Dow futures remain flat, reflecting anticipation for Nvidia's upcoming earnings report.
  • Nvidia Export Controls: U.S. officials confirmed that Nvidia has not yet sold its flagship H200 chips to China, despite recent export approvals, raising market concerns about future sales and potential spillover effects on competitors like AMD and Intel.
  • M&A Tensions: Warner Bros. Discovery stated that Paramount Global's revised $31 billion acquisition bid may be superior to its existing deal with Netflix, intensifying market focus on media sector mergers and potentially impacting the stock performance of involved companies.
  • Healthcare Policy Changes: Trump announced plans to end Affordable Care Act premium tax credits during his address, redirecting funds to consumers instead of large insurance companies, which could have significant implications for the healthcare insurance industry, particularly for firms like UnitedHealth.
Fool
9.5
02-17Fool
Health Insurance Stocks Face Challenges and Opportunities
  • Market Share Growth: Oscar Health's insurance membership surged to 3.4 million in 2025 from just 400,000 at the end of 2020, showcasing its competitive edge in the individual health insurance market despite risks from expiring subsidies.
  • Revenue Recovery Outlook: Oscar Health projects its revenue to rise from $11.7 billion in 2025 to as high as $19 billion in 2026, with operating earnings expected between $250 million and $450 million, indicating strong performance in price increases and customer retention.
  • Legacy Insurer Rebound: UnitedHealth Group anticipates generating $439 billion in revenue and $24 billion in operating earnings in 2026, despite facing challenges like cybersecurity incidents and antitrust lawsuits, highlighting its robust market position and profitability.
  • Valuation Appeal: With a current market cap of $260 billion, UnitedHealth trades at just over 10 times its operating income, suggesting that, given rising healthcare inflation and an aging population, the stock may be undervalued and present a solid investment opportunity in the coming years.
Benzinga
9.5
02-12Benzinga
Oscar Health Stock Gains: Key Insights
  • Earnings Report: Oscar Health reported a quarterly loss of $1.24 per share, which was wider than the expected $0.89 loss and a significant decline from last year's $0.62 loss; however, revenue grew 17% year-over-year to $2.81 billion, albeit below the consensus of $3.12 billion.
  • Guidance Outlook: The company provided a revenue guidance for 2026 of $18.7 billion to $19.0 billion, significantly exceeding Wall Street's estimate of $12.565 billion, indicating strong growth potential, while expecting a medical loss ratio between 82.4% and 83.4% and operating earnings between $250 million and $450 million.
  • Upgrade Impact: Raymond James anticipates Oscar will achieve approximately 2% EBIT margin in 2026, increasing to around 4% in 2027 due to improvements in medical loss ratio and operational efficiencies, with much of the uncertainty regarding ACA subsidies already reflected in the stock price.
  • Stock Movement: As of Thursday, Oscar Health shares rose by 0.96% to $13.73, reflecting market confidence in the company's growth potential despite the disappointing short-term earnings report, while the long-term EPS target remains at $2.25, indicating investor optimism about future performance.
CNBC
6.0
02-12CNBC
Major Wall Street Rating Updates
  • Apple Siri Upgrade Delay: Evercore ISI reiterates Apple as outperform, suggesting that reports of delays in Siri upgrades are overstated, with expectations for a multi-phase rollout of AI features this year, emphasizing the importance of privacy protection and seamless integration.
  • Shopify Attractiveness Upgrade: TD Cowen upgrades Shopify from hold to buy, citing its strong quarterly performance and continued growth momentum as compelling reasons for investors to consider the stock, especially given its recent price decline.
  • Fastly's Stellar Performance: William Blair upgrades Fastly from market perform to outperform following impressive earnings, driven by a significant increase in AI traffic contributions, indicating substantial growth potential in this emerging sector.
  • MercadoLibre's Improved Competitive Landscape: JPMorgan upgrades MercadoLibre from neutral to overweight, noting a reduction in competitive pressures in the Latin American online marketplace, with expectations for sustained growth in the coming quarters.
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
Wall Street analysts forecast OSCR stock price to rise
1 Buy
4 Hold
3 Sell
Hold
Current: 0.000
sliders
Low
11.00
Averages
15.75
High
25.00
Current: 0.000
sliders
Low
11.00
Averages
15.75
High
25.00
Raymond James
Market Perform -> Outperform
upgrade
$18
AI Analysis
2026-02-12
Reason
Raymond James
Price Target
$18
AI Analysis
2026-02-12
upgrade
Market Perform -> Outperform
Reason
Raymond James upgraded Oscar Health to Outperform from Market Perform with an $18 price target. The stock's relative valuation is attractive at current levels as the company's margins recover across the Affordable Care Act exchange market, the analyst tells investors in a research note. Raymond James sees Oscar Health as the "best house in a tough neighborhood." The firm says the company's Q4 miss is backwards looking and that its forward-looking outlook is "more supportive."
UBS
Jonathan Yong
Neutral
downgrade
$17 -> $15
2026-02-11
Reason
UBS
Jonathan Yong
Price Target
$17 -> $15
2026-02-11
downgrade
Neutral
Reason
UBS analyst Jonathan Yong lowered the firm's price target on Oscar Health to $15 from $17 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OSCR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Oscar Health Inc (OSCR.N) is -27.44, compared to its 5-year average forward P/E of 24.94. For a more detailed relative valuation and DCF analysis to assess Oscar Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
24.94
Current PE
-27.44
Overvalued PE
89.47
Undervalued PE
-39.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-29.31
Current EV/EBITDA
-728.67
Overvalued EV/EBITDA
114.76
Undervalued EV/EBITDA
-173.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.49
Current PS
0.31
Overvalued PS
0.97
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

mid-cap stocks about to break bullish
Intellectia · 61 candidates
Market Cap: 2.00B - 10.00BRsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $5.00Support Resistance Relationship: PriceBreakResistance
Ticker
Name
Market Cap$
top bottom
PLUG logo
PLUG
Plug Power Inc
3.11B
INTA logo
INTA
Intapp Inc
2.10B
BWIN logo
BWIN
Baldwin Insurance Group Inc
3.18B
WIX logo
WIX
Wix.Com Ltd
4.60B
SM logo
SM
SM Energy Co
5.74B
RCUS logo
RCUS
Arcus Biosciences Inc
2.81B
what are some day trades i can do with 300$
Intellectia · 122 candidates
Region: USPrice: $1.00 - $30.00Price Change Pct: $3.00 - $100.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
UWMC logo
UWMC
UWM Holdings Corp
6.66B
PATH logo
PATH
UiPath Inc
5.32B
AAL logo
AAL
American Airlines Group Inc
8.80B
OPEN logo
OPEN
Opendoor Technologies Inc
4.77B
RGTI logo
RGTI
Rigetti Computing Inc
5.82B
LUNR logo
LUNR
Intuitive Machines Inc
3.23B
which stock will moon this year?
Intellectia · 722 candidates
Market Cap: >= 1000.00MQuarter Revenue Yoy Growth: >= 0.0%Revenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEYtd Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
TGTX logo
TGTX
TG Therapeutics Inc
5.02B
MARA logo
MARA
MARA Holdings Inc
3.89B
IREN logo
IREN
IREN Ltd
17.19B
LCID logo
LCID
Lucid Group Inc
3.72B
SMR logo
SMR
Nuscale Power Corp
6.25B
CLSK logo
CLSK
CleanSpark Inc
3.37B
best stocks for November
Intellectia · 19 candidates
Beta: ModerateRisk, HighRiskWeekly Average Turnover: >= 20,000,000Pe Ttm: <= 15Month Price Change Pct: >= $0.00Annual Eps Yoy Growth: >= 40.0%Annual Revenue Yoy Growth: >= 40.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
UAMY logo
UAMY
United States Antimony Corp
1.28B
BKKT logo
BKKT
Bakkt Holdings Inc
533.40M
ARDX logo
ARDX
Ardelyx Inc
1.94B
GROY logo
GROY
Gold Royalty Corp
1.10B
TWO logo
TWO
Two Harbors Investment Corp
1.40B

Whales Holding OSCR

B
BIT Capital GmbH
Holding
OSCR
-6.45%
3M Return
S
Sessa Capital IM, L.P.
Holding
OSCR
-10.80%
3M Return
D
Dragoneer Investment Group, LLC
Holding
OSCR
-17.91%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Oscar Health Inc (OSCR) stock price today?

The current price of OSCR is 13.4 USD — it has increased 0.75

What is Oscar Health Inc (OSCR)'s business?

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

What is the price predicton of OSCR Stock?

Wall Street analysts forecast OSCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is15.75 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Oscar Health Inc (OSCR)'s revenue for the last quarter?

Oscar Health Inc revenue for the last quarter amounts to 2.81B USD, increased 17.30

What is Oscar Health Inc (OSCR)'s earnings per share (EPS) for the last quarter?

Oscar Health Inc. EPS for the last quarter amounts to -1.24 USD, increased 100.00

How many employees does Oscar Health Inc (OSCR). have?

Oscar Health Inc (OSCR) has 2305 emplpoyees as of March 12 2026.

What is Oscar Health Inc (OSCR) market cap?

Today OSCR has the market capitalization of 3.99B USD.